Study details
Enrolling now
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Memorial Sloan Kettering Cancer Center
NCT IDNCT06130280ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
32
Study length
about 3.1 years
Ages
18+
Locations
7 sites in NJ, NY
About this study
This trial is testing if a single session of high-dose contrast-enhanced MRI-guided SBRT can prevent liver metastasis from growing and spreading. The researchers will also evaluate side effects and see if certain MRI image characteristics predict how well the treatment works.
Based on ClinicalTrials.gov records.
What participants do
- 1.Receive MR Guided Single Fraction Stereotactic Body Radiation Therapy (SBRT)
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Procedures
radiation
Body systems
Gastroenterology, Oncology